DK2182960T3 - Forbindelser, formuleringer og fremgangsmåder til reducering af hudrynker, furer og slaphed - Google Patents
Forbindelser, formuleringer og fremgangsmåder til reducering af hudrynker, furer og slaphedInfo
- Publication number
- DK2182960T3 DK2182960T3 DK08794808.9T DK08794808T DK2182960T3 DK 2182960 T3 DK2182960 T3 DK 2182960T3 DK 08794808 T DK08794808 T DK 08794808T DK 2182960 T3 DK2182960 T3 DK 2182960T3
- Authority
- DK
- Denmark
- Prior art keywords
- slackness
- furrows
- formulations
- compounds
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/04—Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/70—Biological properties of the composition as a whole
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95229807P | 2007-07-27 | 2007-07-27 | |
PCT/US2008/009117 WO2009017705A1 (en) | 2007-07-27 | 2008-07-28 | Compounds, formulations, and methods for reducing skin wrinkles, creasing and sagging |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2182960T3 true DK2182960T3 (da) | 2014-05-26 |
Family
ID=40304650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK08794808.9T DK2182960T3 (da) | 2007-07-27 | 2008-07-28 | Forbindelser, formuleringer og fremgangsmåder til reducering af hudrynker, furer og slaphed |
Country Status (10)
Country | Link |
---|---|
US (3) | US20090060852A1 (da) |
EP (1) | EP2182960B1 (da) |
CY (1) | CY1115130T1 (da) |
DK (1) | DK2182960T3 (da) |
ES (1) | ES2463717T3 (da) |
HR (1) | HRP20140397T1 (da) |
PL (1) | PL2182960T3 (da) |
PT (1) | PT2182960E (da) |
SI (1) | SI2182960T1 (da) |
WO (1) | WO2009017705A1 (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8410102B2 (en) | 2003-05-27 | 2013-04-02 | Galderma Laboratories Inc. | Methods and compositions for treating or preventing erythema |
US7812049B2 (en) | 2004-01-22 | 2010-10-12 | Vicept Therapeutics, Inc. | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
US20090060852A1 (en) | 2007-07-27 | 2009-03-05 | Jack Dejovin | Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging |
SI2818184T1 (sl) | 2007-11-16 | 2019-03-29 | Aclaris Therapeutics, Inc. | Sestava in postopki za zdravljenje purpure |
EP2262469A4 (en) * | 2008-04-15 | 2013-12-04 | Immanence Integrale Dermo Correction Inc | SKIN CARE COMPOSITIONS AND METHODS OF USE |
US8450475B2 (en) | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
WO2010115081A2 (en) * | 2009-04-02 | 2010-10-07 | Allergan, Inc. | Hair-like shaped hydrogels for soft tissue augmentation |
WO2010136585A2 (en) * | 2009-05-29 | 2010-12-02 | Galderma Research & Development | Combination of adrenergic receptor agonist -1 or -2, preferably brimonidine with fillers, preferablyhyaluronic acid |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
HUE033143T2 (en) | 2010-03-26 | 2017-11-28 | Galderma Res & Dev | Preparations containing brimonidine for the treatment of erythema |
JP5747392B2 (ja) | 2010-03-26 | 2015-07-15 | ガルデルマ・リサーチ・アンド・デヴェロップメント | 毛細血管拡張症の安全かつ有効な治療のための改善された方法および組成物 |
US20120076738A1 (en) * | 2010-09-28 | 2012-03-29 | Michael Graeber | Combination treatment for dermatological conditions |
RU2571277C2 (ru) | 2010-10-21 | 2015-12-20 | Галдерма С.А. | Композиции геля с бримонидином и способы применения |
US8053427B1 (en) | 2010-10-21 | 2011-11-08 | Galderma R&D SNC | Brimonidine gel composition |
WO2013052770A1 (en) | 2011-10-05 | 2013-04-11 | Sanders Jennifer L | Methods and compositions for treating foot or hand pain |
BR112015024113A2 (pt) * | 2013-03-20 | 2017-07-18 | Hoffmann La Roche | derivados de uréia e seu uso como inibidores da proteína de ligação de ácido graxo (fabp) |
ES2693771T3 (es) * | 2014-01-29 | 2018-12-13 | Bristol-Myers Squibb Company | Inhibidores de aril lactama quinasa |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4164570A (en) * | 1973-09-24 | 1979-08-14 | David Clough | Stabilized aqueous catecholamine solutions |
US4285967A (en) * | 1978-06-30 | 1981-08-25 | Estee Lauder Inc. | Cosmetic preparation for reducing redness of blemishes |
US4256763A (en) * | 1978-09-19 | 1981-03-17 | Mchugh John E | Treatment of herpes simplex infections and acne |
US5256652A (en) * | 1987-11-12 | 1993-10-26 | Pharmedic Co. | Topical compositions and methods for treatment of male impotence |
FR2648709A1 (fr) * | 1989-06-23 | 1990-12-28 | Boehringer Ingelheim France | Nouvelle utilisation de derives de 1-phenyl-2-aminoethanol en tant que moyens cicatrisants |
US5012797A (en) * | 1990-01-08 | 1991-05-07 | Montefiore Hospital Association Of Western Pennsylvania | Method for removing skin wrinkles |
US5254331A (en) * | 1991-09-12 | 1993-10-19 | Chanel, Inc. | Skin cream composition |
JPH07506367A (ja) * | 1992-05-05 | 1995-07-13 | ザ、プロクター、エンド、ギャンブル、カンパニー | アクネ治療組成物 |
US5643586A (en) * | 1995-04-27 | 1997-07-01 | Perricone; Nicholas V. | Topical compositions and methods for treatment of skin damage and aging using catecholamines and related compounds |
DE29612123U1 (de) * | 1996-07-11 | 1996-09-12 | Kafl, Johann, 83730 Fischbachau | Dermapermeables (hautdurchlässiges) Gel (Salbe) zur subcutanen Lipidmetabolisierung (Unterhautfettverbrennung) und Behandlung von Cellulite |
US5916574A (en) * | 1996-10-09 | 1999-06-29 | Ideal Ideas, Inc. | Method of treating natural poison skin conditions |
US5910312A (en) * | 1996-10-09 | 1999-06-08 | Ideal Ideas, Inc. | Acne treatment composition with vasoconstrictor |
ES2220257T1 (es) * | 1998-03-11 | 2004-12-16 | Kabushiki Kaisha Soken | Agentes normalizadores para la piel. |
US5989528A (en) * | 1998-07-30 | 1999-11-23 | The Procter & Gamble Company | Sunscreen compositions |
US6444647B1 (en) * | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
US20040266776A1 (en) * | 2003-06-25 | 2004-12-30 | Gil Daniel W. | Methods of preventing and reducing the severity of stress-associated conditions |
JP2004196759A (ja) * | 2002-12-18 | 2004-07-15 | Takashi Suzuki | ビタミンk類とビタミンe複合の美肌化粧料 |
US7439241B2 (en) * | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
US20050020600A1 (en) * | 2003-07-23 | 2005-01-27 | Scherer Warren J. | Methods of treating cutaneous flushing using selective alpha-2-adrenergic receptor agonists |
US7288263B2 (en) * | 2004-09-13 | 2007-10-30 | Evera Laboratories, Llc | Compositions and methods for treatment of skin discoloration |
US7776915B2 (en) * | 2005-03-24 | 2010-08-17 | Tracie Martyn International, Llc | Topical formulations and methods of use |
US20060275228A1 (en) * | 2005-05-09 | 2006-12-07 | Bissett Donald L | Skin care compositions containing idebenone |
US20070082070A1 (en) * | 2005-10-11 | 2007-04-12 | Stookey Evangeline L | Treating skin disorders |
US7252816B1 (en) * | 2006-03-29 | 2007-08-07 | Dow Pharmaceutical Sciences | Topical acne vulgairs medication with a sunscreen |
US20090060852A1 (en) | 2007-07-27 | 2009-03-05 | Jack Dejovin | Compounds, Formulations and Methods for Reducing Skin Wrinkles, Creasing and Sagging |
-
2008
- 2008-07-28 US US12/180,790 patent/US20090060852A1/en not_active Abandoned
- 2008-07-28 PL PL08794808T patent/PL2182960T3/pl unknown
- 2008-07-28 SI SI200831221T patent/SI2182960T1/sl unknown
- 2008-07-28 EP EP08794808.9A patent/EP2182960B1/en active Active
- 2008-07-28 PT PT87948089T patent/PT2182960E/pt unknown
- 2008-07-28 ES ES08794808.9T patent/ES2463717T3/es active Active
- 2008-07-28 WO PCT/US2008/009117 patent/WO2009017705A1/en active Application Filing
- 2008-07-28 DK DK08794808.9T patent/DK2182960T3/da active
-
2011
- 2011-08-02 US US13/196,333 patent/US8440688B2/en active Active
-
2013
- 2013-04-15 US US13/862,570 patent/US20130243837A1/en not_active Abandoned
-
2014
- 2014-05-02 HR HRP20140397AT patent/HRP20140397T1/hr unknown
- 2014-05-23 CY CY20141100364T patent/CY1115130T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1115130T1 (el) | 2016-12-14 |
US20110286945A1 (en) | 2011-11-24 |
PL2182960T3 (pl) | 2014-08-29 |
US20130243837A1 (en) | 2013-09-19 |
HRP20140397T1 (hr) | 2014-06-20 |
EP2182960A1 (en) | 2010-05-12 |
US20090060852A1 (en) | 2009-03-05 |
SI2182960T1 (sl) | 2014-07-31 |
PT2182960E (pt) | 2014-06-11 |
WO2009017705A1 (en) | 2009-02-05 |
EP2182960B1 (en) | 2014-03-19 |
EP2182960A4 (en) | 2010-10-27 |
ES2463717T3 (es) | 2014-05-29 |
US8440688B2 (en) | 2013-05-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2182960T3 (da) | Forbindelser, formuleringer og fremgangsmåder til reducering af hudrynker, furer og slaphed | |
DK2300443T3 (da) | Triazolderivater, der er anvendelige til behandling af sygdomme | |
DK3424932T3 (da) | Bronophthalider til terapeutisk anvendelse | |
DK3428148T3 (da) | Aryloazol-2-yl-cyanoethylaminoforbindelser, fremgangsmåde til fremstilling og fremgangsmåde til anvendelse deraf | |
DK2121139T3 (da) | Formulations for cancer treatment | |
DK3456707T3 (da) | 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme | |
DK2222675T3 (da) | 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse | |
DK2504005T3 (da) | Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme | |
DK2358669T3 (da) | Alpha-keto-persyrer og fremgangsmåder til fremstilling og anvendelse heraf | |
DK2209375T3 (da) | Parp-inhibitorforbindelser, præparater og fremgangsmåder til anvendelse deraf | |
DK2229360T3 (da) | Indolinonderivater og fremgangsmåde til deres fremstilling | |
DK3058875T3 (da) | System til kosmetisk behandling og billedoptagelse | |
DK2334378T3 (da) | Prodrugs af methylhydrogenfumarat, farmaceutiske sammensætninger deraf og fremgangsmåder til anvendelse | |
DK2270818T3 (da) | Polyelektrolyt og fremgangsmåde til fremstilling af polyelektrolytten | |
NO20076533L (no) | Fremgangsmåte og system for klokkedriftskompensering | |
BRPI0814188A2 (pt) | Formulações | |
DK3338790T3 (da) | Oligopeptid-forbindelser og anvendelser deraf | |
DK2432798T3 (da) | 17-hydroxy-17-pentaflourethyl-estra-4,9(10)-dien-11-aryl-derivat, fremgangsmåde til fremstilling heraf og anvendelse heraf til behandling af sygdomme | |
DK2340042T3 (da) | Fremgangsmåder og præparater til behandling af cancer | |
DK2285808T3 (da) | Spiroindolderivater til behandling af parasitsygdomme | |
DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
BRPI0921947A2 (pt) | formulações de proteína terapêutica | |
BRPI0818598A2 (pt) | agentes terapêuticos - 802 | |
DK2158194T3 (da) | Derivater af 7-alkynyl-1,8-naphtyridoner, fremgangsmåde til fremstilling deraf og terapeutisk anvendelse deraf | |
DK2331057T3 (da) | Sammensætninger og fremgangsmåder til modulering af hudpigmentering |